Alnylam Pharmaceuticals Inc (ALNY)
280.77
-9.93
(-3.42%)
USD |
NASDAQ |
Mar 25, 16:00
280.77
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Max Drawdown (5Y): 42.46% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Pfizer Inc | 54.78% |
| Biomarin Pharmaceutical Inc | 53.26% |
| BridgeBio Pharma Inc | 92.80% |
| Regeneron Pharmaceuticals Inc | 44.76% |
| Vertex Pharmaceuticals Inc | 41.60% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 7.803 |
| Beta (5Y) | 0.3924 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 50.92% |
| Historical Sharpe Ratio (5Y) | 0.2635 |
| Historical Sortino (5Y) | 0.6251 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.33% |